Search

Displaying results 5301 - 5310 of 6949 in total
  1. Drug

    Safimaltib

    go.drugbank.com/drugs/DB21528
    Investigational

    Safimaltib is under investigation in clinical trial NCT06788509 (A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring).

  2. Drug

    Gonyautoxin III

    go.drugbank.com/drugs/DB19187
    Experimental

    Gonyautoxin III is currently under investigation in clinical trial (Gonyautoxin 2/​3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study) for the treatment of Acute Back Pain.

  3. Drug

    Caramiphen

    go.drugbank.com/drugs/DB11504
    ExperimentalVet approved

    Additionally, it is used, in combination with [phenylpropanolamine], as a cough suppressant and nasal decongestant for the symptomatic treatment of seasonal respiratory conditions.

  4. Drug

    CCX915

    go.drugbank.com/drugs/DB05159
    Experimental

    CCX915 is developed by ChemoCentryx which targets the chemokine receptor CCR2 and is in phase 1 of clinical trial for the treatment of Multiple Sclerosis and Neurologic Disorders. … The CCR2 receptor is thought to be of central importance to inflammatory diseases, such as multiple sclerosis (MS), Type II diabetes and atherosclerosis.

  5. Drug

    Liranaftate

    go.drugbank.com/drugs/DB19985
    Experimental

    Liranaftate is a small molecule drug. Liranaftate has a monoisotopic molecular weight of 328.12 Da.

    Categories: Antifungals for Topical Use, Antifungals for Dermatological Use
  6. Drug

    Nicaraven

    go.drugbank.com/drugs/DB06397
    Experimental

  7. Drug

    Dovitinib

    go.drugbank.com/drugs/DB05928
    Investigational

    Chiron currently has three ongoing Phase I clinical trials for dovitinib.

  8. Drug

    RGX-111

    go.drugbank.com/drugs/DB17632
    Investigational

    Developed by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46666]

  9. Drug

    SM-1997

    go.drugbank.com/drugs/DB18670
    Experimental

    [A261816] It is under investigation for the treatment of cutaneous sulfur mustard-induced injury.

  10. Drug

    Tulisokibart

    go.drugbank.com/drugs/DB18719
    Investigational

    It is being investigated for ulcerative colitis.